Approval · Notice of Compliance 4044 · 1997
PYLORID: Notice of Compliance 4044
Issued July 23, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4044
- Date
- July 23, 1997
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Histamine H2-receptor with helicobacter suppressive activity
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PYLORID | 02231831 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE BISMUTH CITRATE 400 MG per TAB